MedPath

The effect of pioglitazone on reducing methamphetamine dependence.

Not Applicable
Recruiting
Conditions
Methamphetamine dependent patients.
Registration Number
IRCT20190427043389N1
Lead Sponsor
Zanjan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Methamphetamine-dependent patients admitted to beheshti hospital in zanjan included in the study.
Methamphetamine-dependent patients referred to the clinic of beheshti training center of zanjan in the study.
The age range of patients is between 20 to 50 years.

Exclusion Criteria

chronic medical conditions include diabetes , severe liver disorder & severe heart disorder.
pioglitazone contraindications if any.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The effect of pioglitazone on treatment outcome of methamphetamine dependent patients. Timepoint: three months. Method of measurement: Based on the nottingham questionnaire.
Secondary Outcome Measures
NameTimeMethod
Determination of quality of life in pioglitazone recipient group. Timepoint: three months. Method of measurement: Based on the nottingham questionnaire.
© Copyright 2025. All Rights Reserved by MedPath